A Retrospective Study of Invasive Fungal Disease Treated by High Dosage Micafungin Therapy VS Standard Micafungin Therapy Among Patients with Hematologic Diseases. [PDF]
, 2021 Jia Li +4 more
openalex +1 more source
PathogensCandida auris is an emerging, multidrug-resistant yeast that causes systemic infections, mainly in hospitalized or immunosuppressed patients. This pathogen has a high mortality and morbidity rate.
Gabriel Davi Marena +12 more
doaj +1 more source
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis [PDF]
, 2005 Karl V. Clemons, David A. Stevens
openalex +1 more source
Identification of ten KB425796-A congeners from Paenibacillus sp. 530603 using an antifungal assay against Aspergillus fumigatus in combination with micafungin [PDF]
, 2013 Hirohito Kai +12 more
openalex +1 more source
Micafungin Breakthrough Fungemia in Patients with Hematological Disorders [PDF]
, 2018 Muneyoshi Kimura +22 more
openalex +1 more source
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. [PDF]
, 2009 Experience with anidulafungin against Candida krusei is limited. Immunosuppressed mice were injected with 1.3 x 10(7) to 1.5 x 10(7) CFU of C. krusei.
Chen, Enuo +4 more
core
Erratum to: Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice [PDF]
, 2015 Beth Burgwyn Fuchs +7 more
openalex +1 more source
Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints [PDF]
, 2023 Maria-Ioanna Beredaki +3 more
openalex +1 more source